These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3019356)

  • 1. Effect of proteases and phospholipases on [3H]yohimbine binding to human platelet membranes.
    Periyasamy S; Somani P
    Biochem Pharmacol; 1986 Sep; 35(18):3131-6. PubMed ID: 3019356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agonist and antagonist binding to alpha 2-adrenergic receptors in purified membranes from human platelets. Implications of receptor-inhibitory nucleotide-binding protein stoichiometry.
    Neubig RR; Gantzos RD; Brasier RS
    Mol Pharmacol; 1985 Nov; 28(5):475-86. PubMed ID: 2865672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of alpha 2-adrenergic receptors in human platelets by binding of a radioactive ligand [3H]yohimbine.
    Mukherjee A
    Biochim Biophys Acta; 1981 Aug; 676(2):148-54. PubMed ID: 6114754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of phospholipase A2 on human blood platelet alpha adrenergic receptor function.
    Rao GH; White JG
    Thromb Res; 1989 Mar; 53(5):427-34. PubMed ID: 2544037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [3H]Yohimbine binding to human platelet membranes: evidence for high and low affinity binding sites with negative cooperativity.
    Periyasamy SM; Somani P
    Eur J Pharmacol; 1985 Oct; 116(1-2):17-24. PubMed ID: 2865159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment of human platelet membranes with trypsin abolishes GTP but not Na+ effects on alpha 2-adrenoreceptor-agonist interactions.
    Periyasamy S; Somani P
    Can J Physiol Pharmacol; 1987 May; 65(5):778-84. PubMed ID: 2887268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of alpha 2-adrenergic receptors of intact and functional washed human platelets by binding of 3H-dihydroergocryptine and 3H-yohimbine--correlation of 3H-yohimbine binding with the potentiation by adrenaline of ADP-induced aggregation.
    Lanza F; Cazenave JP
    Thromb Haemost; 1985 Aug; 54(2):402-8. PubMed ID: 3001964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of guanine nucleotide and sodium in regulation of yohimbine and clonidine binding sites in the HT29 human colon adenocarcinoma cell-line.
    Bouscarel B; Murat JC; Paris H
    Gen Pharmacol; 1985; 16(6):641-4. PubMed ID: 3002903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of agonists with platelet alpha 2-adrenergic receptors.
    Hoffman BB; Michel T; Brenneman TB; Lefkowitz RJ
    Endocrinology; 1982 Mar; 110(3):926-32. PubMed ID: 6120077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha 2-adrenergic receptors on canine platelet membranes characterized by [3H]-yohimbine binding.
    O'Hara N; Yokota S; Kouchi Y; Ono H
    Res Commun Chem Pathol Pharmacol; 1986 May; 52(2):179-94. PubMed ID: 3012728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of chymotrypsin on magnesium, sodium, and guanine nucleotide regulation of alpha 2-adrenoreceptors of human platelets.
    Periyasamy S; Somani P
    Biochem Pharmacol; 1987 Sep; 36(18):3086-8. PubMed ID: 2820431
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased central alpha-2 adrenergic receptors measured with [3H] yohimbine in the presence of sodium ion and guanylnucleotides.
    Woodcock EA; Murley B
    Biochem Biophys Res Commun; 1982 Mar; 105(1):252-8. PubMed ID: 6284145
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization of alpha 2-adrenergic receptors of calf retina membranes by [3H]-rauwolscine and [3H]-RX 781094 binding.
    Convents A; De Backer JP; Vauquelin G
    Biochem Pharmacol; 1987 Aug; 36(15):2497-503. PubMed ID: 3038126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of alpha 2-adrenoceptors in rat cortex but not human platelets can be defined by 8-OH-DPAT, RU 24969 and methysergide.
    Brown CM; MacKinnon AC; McGrath JC; Spedding M; Kilpatrick AT
    Br J Pharmacol; 1990 Mar; 99(3):481-6. PubMed ID: 1970497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of [3H]nitrendipine binding by phospholipases A2 and C through direct and GTP-sensitive mechanisms.
    Finkel MS; Hartsell TL; Oddis CV
    Life Sci; 1992; 50(14):1031-41. PubMed ID: 1313132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of adenylate cyclase-coupled alpha 2-adrenergic receptors in rat renal cortex using [3H]yohimbine.
    Woodcock EA; Johnston CI
    Mol Pharmacol; 1982 Nov; 22(3):589-94. PubMed ID: 6296653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compartmentation of alpha 2-adrenergic receptors in human erythroleukemia (HEL) cells.
    McKernan RM; Howard MJ; Motulsky HJ; Insel PA
    Mol Pharmacol; 1987 Aug; 32(1):258-65. PubMed ID: 3039340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uncoupling by proteolysis of alpha-adrenergic receptor-mediated inhibition of adenylate cyclase in human platelets.
    Ferry N; Adnot S; Borsodi A; Lacombe ML; Guellaën G; Hanoune J
    Biochem Biophys Res Commun; 1982 Sep; 108(2):708-14. PubMed ID: 6293500
    [No Abstract]   [Full Text] [Related]  

  • 19. p-[125I]iodoclonidine is a partial agonist at the alpha 2-adrenergic receptor.
    Gerhardt MA; Wade SM; Neubig RR
    Mol Pharmacol; 1990 Aug; 38(2):214-21. PubMed ID: 1974694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solubilization of human platelet alpha-adrenergic receptors: evidence for agonist-promoted receptor-effector association.
    Limbird LE; MacMillan ST; Smith SK
    Adv Cyclic Nucleotide Res; 1981; 14():189-98. PubMed ID: 6116384
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.